4
Changes in Ownership
CITIUS ONCOLOGY, INC. Filed Acc 0001213900-24-109376
Options or other derivatives
- Director acquired 250,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Mayersohn Joel David Director | 2024-12-12 | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…